
### [NCIT:C5611](http://purl.obolibrary.org/obo/NCIT_C5611)
**Label:** Anal Sarcoma

**Subclasses:** [NCIT:C5602](http://purl.obolibrary.org/obo/NCIT_C5602) (Anal Kaposi Sarcoma), [NCIT:C5599](http://purl.obolibrary.org/obo/NCIT_C5599) (Anal Leiomyosarcoma), [NCIT:C5610](http://purl.obolibrary.org/obo/NCIT_C5610) (Anal Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38828](http://purl.obolibrary.org/obo/NCIT_C38828) (Inositol Phosphate Metabolism Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 39.52%


